Real-time updates from the world of business, finance, and technology.
GrowthPal has raised USD 2.6 million in a new funding round. The company plans to expand its AI-led M&A platform in the US and other markets.
Project Eleven has raised $20 million in a Series A round to help secure digital assets against future quantum threats. The company plans to launch its next product in early 2026.
Deepgram announced it has raised USD 130 million in a Series C funding round. New capital will help grow its real-time voice AI platform and build new services.
Atomic Insights has raised $10 million in seed funding led by Aquiline. The fintech startup builds tools to simplify money movement for RIAs and family offices.
European cybersecurity startup Aikido has raised $60 million in Series B funding. The round values the company at $1 billion, making it the fastest cyber unicorn in Europe.
OpenAI has acquired US-based health-tech startup Torch. The deal is valued at more than USD 100 million and strengthens OpenAI’s push into healthcare.
Meld has raised $7 million in a strategic funding round to grow its global payments network. The company plans to scale sales, expand into new markets, and support more stablecoin use cases.
AI startup Aivar has raised USD 4.6 million. No details on the round type or investors. The company focuses on making AI experiments ready for enterprise use.
Barcelona-based Zynap raised EUR 6 million in a Seed round extension. Existing investors Kibo Ventures and Kfund put in more. This takes the total funding to EUR 12 million.
AI marketing platform Nitro Commerce has raised USD 5 million in a Series A round. The round was led by Cornerstone Ventures with several other investors joining. The funds will go toward scaling in India and abroad, better AI tools, and hiring.
Soley Therapeutics has raised $200 million in a Series C round to move its lead oncology assets into the clinic. The funding will also be used to scale its cell stress sensing platform and expand its broader pipeline.
Parabilis Medicines has closed an oversubscribed $305 million Series F financing to advance its lead cancer drug candidate FOG-001 and expand its Helicon peptide platform. The round was co-led by RA Capital, Fidelity, and Janus Henderson at a higher valuation than the company’s previous financing.
